Regenerative medicine: targeted genome editing in vivo

被引：0

作者：

Lixia Wang

Jun Wu

Weiwei Fang

Guang-Hui Liu

Juan Carlos Izpisua Belmonte

机构：

[1] National Laboratory of Biomacromolecules,

[2] Institute of Biophysics,undefined

[3] Chinese Academy of Sciences,undefined

[4] Gene Expression Laboratory,undefined

[5] Salk Institute for Biological Studies,undefined

[6] Beijing Hospital of the Ministry of Health,undefined

[7] Beijing Institute for Brain Disorders,undefined

[8] Center for Molecular and Translational Medicine,undefined

来源：

Cell Research | 2015年 / 25卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

引用

页码：271 / 272

页数：1